TG Therapeutics | TGTX - Dochód Netto





Dochód Netto Zmiana Data
AbbVie USD 695M 1.12B 2026-03
Alaunos Therapeutics USD -1.16M 108K 2025-09
Amgen USD 1.82B 486M 2026-03
Ardelyx USD -407K 562K 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Biogen USD 319.5M 368.4M 2026-03
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Curis USD 19.36M 31.16M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 5.24B 119M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Novartis USD 3.16B 747M 2026-03
Novavax USD 17.53M 219.91M 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Verastem USD -32.92M 24.66M 2025-12
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03